We believe biotechnology will redefine human health over the next century.

Bioverge partners with visionary founders and breakthrough biotechnology companies advancing the frontier of medicine.

OUR PERSPECTIVE

We believe humanity is entering a new technological era in medicine.

Advances in biology, computation, genetic engineering, artificial intelligence, and cellular therapeutics are reshaping what is possible in human health.

The next generation of transformative companies will not simply improve existing therapies — they will redefine how disease is understood, prevented, and treated.

Bioverge exists to support the scientists and entrepreneurs building that future.

AREAS OF INTEREST

GENETIC MEDICINE

AI-DRIVEN DRUG DISCOVERY

CELL THERAPY

IMMUNOLOGY

NEUROSCIENCE

PRECISION MEDICINE

LONGEVITY

SYNTHETIC BIOLOGY

FOUNDER

Neil Littman

Founder & Managing Partner

Neil Littman is the founder of Bioverge and a biotechnology investor and operator focused on breakthrough therapeutics and emerging technologies in human health.

His background spans venture capital, biotechnology business development, and company building across both private and public markets.

The most important technologies of the next century may emerge from biology.

We believe the companies shaping that future will change not only medicine, but the trajectory of human life itself.